July 31, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · DOI: 10.1200/JCO-26-00677

Dexamethasone-Free Antiemetic Prophylaxis for Children and Adolescents Receiving Highly Emetogenic Chemotherapy: A Multicenter, Phase III, Noninferiority Trial (CIVIC POD)

Listen to this summary

The study aimed to determine whether olanzapine could serve as a noninferior alternative to the standard dexamethasone-based regimen for preventing chemotherapy-induced nausea and vomiting (CINV) in children and adolescents receiving highly emetogenic chemotherapy. The results indicated that olanzapine provided comparable control of vomiting without the use of dexamethasone, suggesting it may be a viable corticosteroid-sparing option for pediatric CINV prophylaxis. However, olanzapine was associated with a higher incidence of somnolence.

Venkatraman Radhakrishnan, Prasanth Srinivasan, Gargi Das, Sameer Bakhshi, Amita Mahajan, Prasanth Ganesan, Balaji Thiruvengadam Kothandan, Ramandeep Singh Arora, Swathi Parmpalli Manjunath, Shuvadeep Ganguly, Deepam Pushpam, Minakshi Bansal, Swaminathan Keerthivasagam, Aparajita Sharma, Aastha Goel, Mubina Begum, Aleeza Khan, Swaminathan Rajaraman

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play